Evidence map›Paper›PMID 32155260›Full record

ArticleHuman reproduction (Oxford, England)2020

The birth of a baby with mosaicism resulting from a known mosaic embryo transfer: a case report.

Semra Kahraman, Murat Cetinkaya, Beril Yuksel, Mesut Yesil, Caroline Pirkevi Cetinkaya

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Human reproduction (Oxford, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 2 pooled it
23.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 2 syntheses or guidelines pooled it, 115 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. In vitro fertilization as an option for couples with genetic disorders.Clinical and experimental reproductive medicine · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Semra KahramanIstanbul Memorial Hospital, Assisted Reproductive Technologies and Reproductive Genetics Center, Piyale Pasa Bulvari 34385, Sisli, Istanbul, Turkey.
Murat CetinkayaIstanbul Memorial Hospital, Assisted Reproductive Technologies and Reproductive Genetics Center, Piyale Pasa Bulvari 34385, Sisli, Istanbul, Turkey.
Beril YukselIstanbul Memorial Hospital, Assisted Reproductive Technologies and Reproductive Genetics Center, Piyale Pasa Bulvari 34385, Sisli, Istanbul, Turkey.
Mesut YesilIstanbul Memorial Hospital, Assisted Reproductive Technologies and Reproductive Genetics Center, Piyale Pasa Bulvari 34385, Sisli, Istanbul, Turkey.
Caroline Pirkevi CetinkayaIstanbul Memorial Hospital, Assisted Reproductive Technologies and Reproductive Genetics Center, Piyale Pasa Bulvari 34385, Sisli, Istanbul, Turkey.
Istanbul Memorial Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mosaic embryos have the potential to implant and develop into healthy babies. The transfer of mosaic embryos is now considered to be a possible option for women undergoing ART with preimplantation genetic testing for aneuploidies and in the absence of euploid embryos, particularly those with diminished ovarian reserve and/or advanced maternal age. It can aid in avoiding the discard of potentially viable embryos, which might otherwise result in healthy babies. In over 500 studies on mosaicism, there have been no reports of mosaicism in babies born following the transfer of mosaic embryos. Here, we present a case report of a 39-year-old woman with diminished ovarian reserve with only one blastocyst available for trophectoderm biopsy. The transfer of the embryo, which showed 35% mosaicism of monosomy 2, resulted in pregnancy. Amniocentesis revealed a mosaic trisomic mos46,XX(98)/47,XX,+2(2) karyotype. There were no pathological findings in detailed ultrasonography, and the fetus showed a normal fetal growth with no evidence of intrauterine growth retardation. A healthy female baby was born at Week 37. The peripheral blood chromosome analysis validated with fluorescence in situ hybridization showed 2% mosaic monosomy 2 [mos45,XX,-2(2)/46,XX(98)]. This is the first reported case of true fetal mosaicism resulting in a live birth following the transfer of a known mosaic embryo. Worldwide, prenatal diagnosis has shown the depletion of mosaicism in embryos transferred after they have been reported as mosaics. Our case demonstrates the need for close prenatal monitoring and diagnosis by early amniocentesis, preferably at >14 weeks gestation.

Indexed as

MosaicismPreimplantation DiagnosisAdultEmbryo TransferFemaleHigh-Throughput Nucleotide SequencingHumansIn Situ Hybridization, FluorescencePregnancybaby with mosaicismmosaic embryo transfernext-generation sequencingpreimplantation genetic testingtrue fetal mosaicism

Identifiers

PMID32155260
PMCPMC7105348
OpenAlexW3011729098

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.